Endothelin B receptor expression correlates with tumour angiogenesis and prognosis in oesophageal squamous cell carcinoma

Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma

(2012) K. Enomoto et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Role of the endothelin axis and its antagonists in the treatment of cancer

(2011) A Bagnato et al.   BRITISH JOURNAL OF PHARMACOLOGY

CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases

(2011) Daniela Wuttig et al.   INTERNATIONAL JOURNAL OF CANCER

Endothelin B Receptor Expression in Human Astrocytoma: Association With Clinicopathological Variables and Survival Outcomes

(2011) Chenfu Shen et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Perioperative management of esophageal cancer

(2010) Alicia Okines et al.   Nature Reviews Clinical Oncology

Outcome of Low-Volume Surgery for Esophageal Cancer in a High-Volume Referral Center

(2009) Ewout F. W. Courrech Staal et al.   ANNALS OF SURGICAL ONCOLOGY

Endothelin-1 Stimulates Lymphatic Endothelial Cells and Lymphatic Vessels to Grow and Invade

(2009) F. Spinella et al.   CANCER RESEARCH

Endothelin B Receptor, a New Target in Cancer Immune Therapy

(2009) L. E. Kandalaft et al.   CLINICAL CANCER RESEARCH

Elevation of circulating big endothelin-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma

(2008) Wenjie Jiao et al.   BMC CANCER

The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapyThis article is one of a selection of papers published in the special issue (part 2 of 2) on Forefronts in Endothelin.

(2008) Anna Bagnato et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Identification of aberrant promoter methylation ofEDNRBgene in esophageal squamous cell carcinoma

(2008) B.-J. Zhao et al.   DISEASES OF THE ESOPHAGUS

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy

(2007) Ronald J Buckanovich et al.   NATURE MEDICINE